PBE
Invesco Biotechnology & Genome ETF
1W: -2.2%
1M: -3.7%
3M: +3.4%
YTD: +15.4%
1Y: +32.7%
3Y: +64.8%
5Y: +23.5%
$95.07
-0.03 (-0.03%)
Weekly Expected Move ±2.9%
$90
$92
$95
$98
$101
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
Key Statistics
AUM$290M
Holdings31
Top 10 Wt48.2%
Volume18,132
Avg Volume21,640
Beta0.79
Portfolio Fundamentals
P/E39.5
P/B7.0
Div Yield0.50%
ROE13.2%
% Profitable68%
Inception2005-06-23
Sector Allocation
Healthcare
99.9%
Financial Services
0.1%
Other
0.0%
Top 10 Holdings
| # | Name | Ticker | Weight % | Market Value | Shares |
|---|---|---|---|---|---|
| 1 | Natera Inc | NTRA | 6.23% | $26.4M | 63,892 |
| 2 | Illumina Inc | ILMN | 6.17% | $26.2M | 95,618 |
| 3 | Biogen Inc | BIIB | 5.19% | $22.0M | 97,446 |
| 4 | Gilead Sciences Inc | GILD | 5.08% | $21.6M | 144,606 |
| 5 | Amgen Inc | AMGN | 4.84% | $20.5M | 48,646 |
| 6 | Vertex Pharmaceuticals Inc | VRTX | 4.80% | $20.3M | 38,913 |
| 7 | Royalty Pharma PLC | RPRX | 4.77% | $20.2M | 346,593 |
| 8 | Regeneron Pharmaceuticals Inc | REGN | 4.62% | $19.6M | 25,808 |
| 9 | Moderna Inc | MRNA | 3.36% | $14.2M | 73,884 |
| 10 | Novavax Inc | NVAX | 3.17% | $13.4M | 1,243,050 |